Table 2. Univariate analysis of survival outcomes in patients with SVZ-involved tumors.
Characteristic | PFS | OS | ||||
---|---|---|---|---|---|---|
p | HR | 95% CI | p | HR | 95% CI | |
Age ≥40 years | 0.024 | 2.259 | 1.116–4.574 | 0.047 | 2.093 | 1.009–4.338 |
Sex (Male) | 0.718 | 1.149 | 0.541–2.441 | 0.781 | 1.118 | 0.508–2.462 |
KPS <80 | 0.375 | 1.543 | 0.592–4.024 | 0.351 | 1.584 | 0.603–4.160 |
Volume ≥60 cm3 | 0.043 | 2.145 | 1.025–4.492 | 0.030 | 2.349 | 1.085–5.084 |
CS ≤30 mm | 0.061 | 1.977 | 0.970–4.027 | 0.026 | 2.353 | 1.108–4.919 |
Regions contacting SVZ | ||||||
Frontal horn/others | 0.850 | 1.070 | 0.528–2.171 | 0.700 | 1.156 | 0.554–2.409 |
<GTR | 0.018 | 4.227 | 1.284–13.909 | 0.012 | 6.278 | 1.491–26.431 |
Radiation | 0.504 | 0.747 | 0.318–1.756 | 0.333 | 0.652 | 0.275–1.548 |
Chemotherapy | 0.752 | 1.139 | 0.508–2.553 | 0.618 | 1.232 | 0.544–2.789 |
CI, confidence interval; CS, the shortest distance from the tumor centroid to the edge of the lateral ventricles; GTR, gross total resection; HR, hazard ratio; KPS, Karnofsky Performance Status scale; OS, overall survival; PFS, progression-free survival; SVZ, subventricular zone.